Abstract
The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Current Respiratory Medicine Reviews
Title:The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Volume: 8 Issue: 5
Author(s): Jose M. Porcel
Affiliation:
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Abstract: The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Export Options
About this article
Cite this article as:
Porcel M. Jose, The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice, Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832485
DOI https://dx.doi.org/10.2174/157339812803832485 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cerebral Angiogenesis and Expression of Angiogenic Factors in Aging Rats after Exercise
Current Neurovascular Research Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk
Adolescent Psychiatry Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Current Gene Therapy Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment
Recent Patents on Anti-Infective Drug Discovery Recent Advances in Antiarrhythmic Drug Treatment of Atrial Fibrillation
Recent Patents on Cardiovascular Drug Discovery Jean-Baptiste de Sénac’s (1693-1770) Important Work on Cardiology and Valvular Disorders
Current Pharmaceutical Design Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Lost in Translation: What is Limiting Cardiomyoplasty and Can Tissue Engineering Help?
Current Stem Cell Research & Therapy Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Current Medicinal Chemistry Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases
Current Pharmaceutical Design The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties
Current Pharmaceutical Design Visceral Adipose Tissue and Atherosclerosis
Current Vascular Pharmacology Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders
Current Chinese Chemistry A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
Current Pharmaceutical Design Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
Current Pharmaceutical Biotechnology Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry